Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia

NCT02250105 is registered in ClinicalTrials.gov with Arisaph Pharmaceuticals Inc as lead sponsor.

NCT NCT02250105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02250105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Lead sponsor
Arisaph Pharmaceuticals Inc
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
June 30, 2016
Enrollment
80 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia